Cognitive functioning in younger and older HIV-1-infected adults

Journal of Acquired Immune Deficiency Syndromes

Volumn 33, Issue SUPPL. 2, 2003, Pages

  Wilkie, Frances L ^a   Goodkin, Karl ^a,b   Khamis, Imad ^a   Van Zuilen, Maria H ^a   Lee, Diana ^a   Lecusay, Robert ^a   Concha, Mauricio ^a   Symes, Stephen ^a   Suarez, Paola ^a   Eisdorfer, Carl ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b University of Miami   (United States)

Author keywords

Aging; CD4 cell count; Cognition; HIV 1 infection; Neuropsychology; Viral load

Indexed keywords

CD4 ANTIGEN;

ADULT; AGED; AGING; ARTICLE; ATTENTION; COGNITION; COGNITIVE DEFECT; DEMENTIA; DISTRESS SYNDROME; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMATION PROCESSING; LEARNING; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEMORY; NEUROLOGICAL COMPLICATION; NEUROPSYCHOLOGY; PRIORITY JOURNAL; PSYCHOLOGIC TEST; RECALL; RISK FACTOR; VIRUS INFECTION;

EID: 0038003160     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200306012-00006     Document Type: Article

References (67)

1. American Academy of Neurology. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus type-1 (HIV-1) infection. Neurology. 1991;41:778-785.
2. Wilkie F, Goodkin K. Cognitive function in HIV-1 infection. In Goodkin K, Visser AP, eds. Psychoneuroimmunology. Stress, mental disorders and health. Washington, DC: American Psychiatric Press, 2000:195-242.
3. Bornstein RA, Nasrallah HA, Para MF, et al. Neuropsychologic performance in symptomatic and asymptomatic HIV infection. AIDS. 1993;7:519-524.
4. Heaton RK, Grant I, Butters N, et al. The HNRC 500 neuropsychology of HIV infection at different disease stages. J Int Neuropsychol Soc. 1995;1:231-251.
5. Ferrando S, van Gorp W, McElhiney M, et al. Highly active antiretroviral treatment in HIV infection: benefits of neuropsychologic function. AIDS. 1998;12(Suppl):F65-70.
6. Sacktor NC, McDermott M, Schifitto G, et al. HIV dementia persists despite highly active antiretroviral therapy (HAART). Neuroscience in HIV infection [abstract W7]. J Neurovirol. 2000;6:244.
7. Tozzi V, Balestra P, Galgani S, et al. Changes in neurocognitive performance in a cohort of patients treated with HAART for 3 years. J Acquir Immune Defic Syndr. 2001;28:19-27.
8. Becker JT, Caldararo R, Lopez OL, et al. Qualitative features of the memory deficit associated with HIV infection and AIDS: cross validation of a discriminant function classification scheme. J Clin Exp Neuropsychol. 1995;17:134-142.
9. Goodkin K, Wilkie FL, Concha M, et al. Subtle neuropsychologic impairment and minor cognitive-motor disorder in HIV-1 infection: neuroradiologic, neurophysiological, neuroimmunologic and virological correlates. Neuroimaging Clin North Am. 1997;7:561-579.
10. Grant I, Marcotte TD, Heaton RK. Neurocognitive complications of HIV disease. Psychol Sci. 1999;10:181-198.
11. Navia BA. The AIDS dementia complex. In Cummings JL, ed. Subcortical dementia. New York: Oxford University Press, 1990:181-198.
12. Peavy G. Jacobs D, Salmon DP, et al. Verbal memory performance of patients with human immunodeficiency virus infection: evidence of subcortical dysfunction. J Clin Exp Neuropsychol. 1994;16:508-523.
13. Sidtis JJ, Price RW. Infectious causes of dementia including human immunodeficiency virus. In Feinberg TE, Farah MJ, eds. Behavioral neurology and neuropsychology. New York: McGrawHill, 1997:605-608.
14. Reger M, Welsh R, Razani J, et al. A meta-analysis of the neuropsychologic sequelae of HIV infection. J Int Neuropsycho Soc. 2002;8:410-424.
15. Wilkie FL, Eisdorfer C, Morgan R, et al. Cognition in early human immunodeficiency virus infection. Arch Neurol. 1990;47:433-440.
16. Eisdorfer C, Wilkie F. The dementias of Alzheimer's and AIDS. In Koslow SH, Murphy RS, Coelho GV, eds. Decade of the brain India/USA research in mental health and neurosciences. Rockville, MD: National Institute of Mental Health: 1990:127-137.
17. van Gorp WG, Mahler M. Subcortical features of normal aging. In Cummings JL, ed. Subcortical dementia. New York: Oxford University Press; 1990:230-250.
18. Miller DB, O'Callaghan JP, Ali SF. Age as a susceptibility factor in the striatal dopaminergic neurotoxicity observed in the mouse following substituted amphetamine exposure. Ann NY Acad Sci. 2000;914:194-207.
19. Bohr VA. Repair of oxidative DNA damage in nuclear and mitochondrial DNA, and some changes with aging in mammalian cells. Free Radic Biol Med. 2002;32:804-812.
20. Lohr JB. Oxygen radicals and neuropsychiatric illness: some speculations. Arch Gen Psychiatry. 1991;48:1097-1106.
21. Finn SF, Hyman BT, Storey E, et al. Effects of age on quinolinic acid lesions in rat striatum. Brain Res. 1991;562:275-280.
22. Jhamandas KH, Boegman RJ, Beninger RJ. The 1993 Upjohn Award Lecture. Quinolinic acid induced brain neurotransmitter deficits: modulation by endogenous excitotoxin antagonists. Can J Physiol Pharmacol. 1994;72:1473-1482.
23. Berger JR, Kumar M, Kumar A, et al. Cerebrospinal fluid dopamine in HIV infection. AIDS. 1994;8:67-71.
24. Sardar AM, Czudek C, Reynolds GP. Dopamine deficits in the brain: the neurochemical basis of Parkinsonian symptoms in AIDS. Neuroreport. 1996;7:910-912.
25. Yamaguchi T, Katoh I, Kurata S. Azidothymidine causes functional and structural destruction of mitochondria, glutathione deficiency and HIC-1 promoter sensitization. Eur J Biochem. 2002;269:2782-2788.
26. Roederer M, Staal FJT, Raju PA, et al. Cytokine-stimulated human immunodeficiency virus replication is inhibited by N-acetyl-L-cysteine. Proc Natl Acad Sci USA. 1990;87:4884-4888.
27. Heyes M, Brew BJ, Martin A, et al. Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurologic status. Ann Neurol. 1991;29:202-209.
28. Janssen RS, Nwanyanwu OC, Selik RM, et al. Epidemiology of human immunodeficiency virus encephalopathy in the United States. Neurology. 1992;42:1472-1476.
29. Navia BA, Price RW. The acquired immunodeficiency syndrome dementia complex as the presenting or sole manifestation of human immunodeficiency virus infection. Arch Neurol. 1987;44:65-69.
30. Chiesi A, Vella S, Dally LG, et al. Epidemiology and AIDS dementia complex in Europe. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;11:39-44.
31. McArthur JC, Hoover DR, Becellar H, et al. Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study. Neurology. 1993;43:2245-2252.
32. van Gorp WG, Miller EN, Marcotte TD, et al. The relationship between age and cognitive impairment in HIV-1 infection: findings from the Multicenter AIDS Cohort Study and clinical cohort. Neurology. 1994;44:929-935.
33. Hardy DJ, Hinkin CH, Satz P, et al. Age differences and neurocognitive performance in HIV-infected adults. NZJ Psychol. 1999;28:94-101.
34. Wilkie FL. Patterns relating neurobehavioral and neuropathologic functioning in older individuals with normal aging, HIV-1 infection, and Alzheimer's disease. Presented at Effects of Age on Neurocognitive and Neuropsychiatric Status over the Course of HIV-1 Infection, National Conference on AIDS and Aging, National Association of HIV Over Fifty, San Francisco, March 1997.
35. Hinkin C, Castellon SA, Atkinson JH, et al. Neuropsychiatric aspects of HIV-infection among older adults. J Clin Epidemiol. 2001;54(Suppl):S41-52.
36. Spitzer RL, Williams JBW, Gibbons M, et al. Structured clinical interview for DSM-III: non-patient version for HIV-1 studies (SCID-NP-HIV). New York: New York State Psychiatric Institute, 1998.
37. First MB, Spitzer RL, Gibbon M, et al. Structured clinical interview for DSM-IV axis I disorders. New York: Biometric Research Department, New York State Psychiatric Institute, 1995.
38. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-571.
39. Spielberger CD, Gorsuch RL, Lushene RE. STAI manual for the state-trait anxiety inventory. Palo Alto, CA: Consulting Psychologists Press, 1970.
40. McNair DM, Lorr M, Droppleman LF. Profile of mood states manual. San Diego, CA: Education Industrial Testing Service, 1971.
41. Williams JBW. Structured interview guide for the Hamilton-depression and anxiety scales (SIGH-AD). New York: New York State Psychiatric Institute; 1988.
42. Lezak MD. Neuropsychologic assessment. New York: Oxford University Press, 1995.
43. Butters N, Grant I, Haby J, et al. Special presentation: assessment of AIDS-related cognitive changes: recommendations of the NIMH Workshop on Neuropsychologic Assessment Approaches. J Clin Exp Neuropsychol. 1990;12:963-978.
44. Wechsler D. Wechsler adult intelligence scale-revised. New York: The Psychological Corporation; 1981.
45. Posner MI, Boies S. Components of attention. Psychol Rev. 1971;78:391-408.
46. Delis DC, Kramer JH, Obser BA. California verbal learning test: adult version. San Antonio, TX: Psychological Corporation; 1987.
47. Ekstrom RB, French JW, Harman HH, et al. Manual for kit of factor-referenced cognitive tests. Princeton, NJ: Educational Testing Service; 1987.
48. Posner MI, Mitchell RF. Chronometric analysis of classification. Psychol Rev. 1967;74:392-409.
49. Martin A, Heyes MP, Salazar AM, et al. Progressive slowing of reaction time and increasing cerebrospinal fluid concentrations of quinolinic acid in HIV-infected individuals. J Neuropsychiatry Clin Neurosci. 1992;4:270-279.
50. Klove H. Clinical neuropsychology. Med Clin North Am. 1963;46:1647-1658.
51. Goodkin K, Antoni MH, Sevin B, et al. A partially testable model of psychosocial factors in the etiology of cervical cancer. II. Bioimmunologic, psychoneuroimmunologic, and socioimmunologic aspects, critique and prospective integration. Psycho-oncology. 1993;2:99-121.
52. Zhang MY, Katzman R, Sakmon D, et al. The prevalence of dementia and Alzheimer's disease in Shanghai, China: impact of age, gender, and education. Ann Neurol. 1990;27:428-437.
53. Satz P. Brain reserve capacity on symptom onset after brain injury: a formulation and review of evidence of threshold theory. Neuropsychology. 1991;7:273-295.
54. Stern RA, Silva SG, Chaisson N, et al. Influence of cognitive reserve on neuropsychologic functioning in asymptomatic human immunodeficiency virus-1 infection. Arch Neurol. 1996;53:148-153.
55. Becker JT, Sanchez J, Dew MA, et al. Neuropsychologic abnormalities among HIV-1 infected individuals in a community-based sample. Neuropsychology. 1997;11:592-601.
56. Pereda M, Ayuso-Mateos JL, Gomez Del Barrio A, et al. Factors associated with neuropsychologic performance in HIV-seropositive subjects without AIDS. Psychol Med. 2000;30:205-217.
57. Basso MR, Bornstein RA. Estimated premorbid intelligence mediates neurobehavioral change in individuals infected with HIV across 12 months. J Clin Exp Neuropsychol. 2000;22:208-218.
58. Maj M, Satz P, Janssen R, et al. WHO Neuropsychiatric AIDS Study, cross-sectional phase II. Neuropsychologic and neurologic findings. Arch Gen Psychiatry. 1995;51:51-61.
59. Salthouse TA. Theoretical perspectives on cognitive aging. Hillsdale, NJ: Lawrence Erlbaum, 1991.
60. Ritchie K, Artero S, Touchon J. Classification criteria for mild cognitive impairment. A population-based validation study. Neurology. 2000;56:1-9.
61. Fujimura RK, Goodkin K, Petito CK. HIV-1 proviral DNA load across neuroanatomic regions of individuals with evidence for HIV-1 associated dementia. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;16:146-152.
62. Shapshak P, Segal DM, Crandall KA, et al. Independent evolution of HIV type 1 in different brain regions. AIDS Res Hum Retrovirol. 1999;15:811-820.
63. Wilkins JW, Robertson KR, van der Horst C, et al. The importance of confounding factors in the evaluation of neuropsychologic changes in patients infected with human immunodeficiency virus. AIDS. 1990;3:938-942.
64. Marcotte TD, Heaton RK, Wolfson T, et al. The impact of HIV-1 related neuropsychologic dysfunction on driving behavior. The HNRC Group. J Int Neuropsychol Soc. 1999;5:579-592.
65. Mayeux R, Stern Y, Tang MX, et al. Mortality risks in gay men with human immunodeficiency virus infection and cognitive impairment. Neurology. 1993;43:2245-2252.
66. Wilkie FL, Goodkin K, Eisdorfer C, et al. Mild cognitive impairment and risk of mortality in HIV-1 infection. J Neuropsychiatry Clin Sci. 1998;10:125-132.
67. Ellis RJ, Deutsch R, Heaton RK, et al. Neurocognitive impairment is an independent risk factor for death in HIV. Arch Neurol. 1997;54:416-424.